Product Details: BPC-157 Nasal Spray
BPC-157 nasal spray is a synthetic peptide derived from a sequence originally identified in gastric protein studies conducted in preclinical environments. Due to its stability and structure, it has become a subject of interest in controlled laboratory investigations.
To support precise administration in experimental settings, researchers have developed a nasal spray formulation designed for accurate and consistent delivery in preclinical models.
This formulation contains a measured peptide solution housed within a spray-based delivery system. The nasal spray format is currently being explored for its potential to facilitate efficient absorption pathways in research models under controlled conditions.
Mechanism of Action
Following administration in preclinical models, BPC-157 inside the bpc nasal spray is theorized to distribute through localized absorption pathways. From there, it may interact with multiple signaling cascades involved in cellular communication and regulation.
Researchers hypothesize that this peptide may influence pathways related to cellular signaling, vascular activity, and structural organization within experimental systems. These interactions are currently being examined to better understand how BPC-157 behaves under controlled laboratory conditions.
Properties of BPC-157 Nasal Spray:
- Molecular Formula: C62H98N16O22
- Molecular Weight: 1419.5 g/mol
- CAS Number: 137525-51-0
- PubChem CID: 9941957
- Synonyms: Bepecin, Bpc 15, pl-10, 8ED8NXK95P
Research Applications/Benefits of BPC-157 Nasal Spray
Cellular Stability Research
BPC 157 nasal is being investigated for its potential to influence cellular stability under controlled experimental conditions. Early observations suggest that it may interact with signaling pathways involved in maintaining cellular structure and function in preclinical models.
Regulatory Pathway Investigation
Researchers are studying how BPC-157 may affect regulatory pathways associated with biochemical signaling. In experimental environments, it is hypothesized to modulate communication between cells, contributing to coordinated responses within biological systems.
Vascular Activity Studies
BPC-157 nasal spray is also being examined for its potential interaction with pathways related to vascular activity in research models. Preliminary findings suggest that it may play a role in signaling processes associated with circulation dynamics in controlled settings.
Absorption Pathway Analysis
The nasal spray formulation itself is being studied for its potential to support alternative absorption pathways in research environments. This delivery method allows investigators to evaluate distribution patterns and uptake efficiency in controlled experimental models.
Why Choose Behemoth Labz to Buy BPC-157 Nasal Spray
At Behemoth Labz, the focus is on delivering research compounds that align with the practical needs of laboratory environments. Our approach emphasizes consistency, transparency, and attention to detail at every stage of production.
Each BPC-157 nasal spray is produced using controlled processes designed to maintain uniformity between batches. This consistency allows researchers to work with greater confidence when conducting repeatable and structured experiments.
We also prioritize clear and accurate product information, ensuring that researchers have access to detailed specifications necessary for proper handling and evaluation in experimental settings.
Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments.
References:
- Sikiric, P., Blagaic, A. B., Strbe, S., Oreskovic, L. B., Oreskovic, I., Sikiric, S., Staresinic, M., Sever, M., Kokot, A., Jurjevic, I., Matek, D., Coric, L., Krezic, I., Tvrdeic, A., Luetic, K., Vuletic, L. B., Pavic, P., Mestrovic, T., Sjekavica, I., . . . Seiwerth, S. (2024). The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Pharmaceuticals, 17(4), 461. https://doi.org/10.3390/ph17040461
- Seiwerth, S., Brcic, L., Vuletic, L., Kolenc, D., Aralica, G., Misic, M., Zenko, A., Drmic, D., Rucman, R., & Sikiric, P. (2014). BPC 157 and blood vessels. Current Pharmaceutical Design, 20(7), 1121–1125. https://doi.org/10.2174/13816128113199990421
- Vasireddi, N., Hahamyan, H., Salata, M. J., Karns, M., Calcei, J. G., Voos, J. E., & Apostolakos, J. M. (2025). Emerging use of BPC-157 in Orthopaedic Sports Medicine: A Systematic review. HSS Journal® the Musculoskeletal Journal of Hospital for Special Surgery, 21(4), 485–495. https://doi.org/10.1177/15563316251355551
1st Party COA
3rd Party COA
Related products
